BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Amarantus BioSciences preclinical data

In rat models of PD, pretreatment with MANF significantly reduced behavioral deficits of neurotoxin-induced lesions. The company said the data confirm results in rat models of PD previously published...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >